July 18, 2025 a 06:00 pm
MRK: Fundamental Ratio Analysis - Merck & Co., Inc.
Merck & Co., Inc. presents robust fundamentals backed by strong collaborations and a rich history in the healthcare sector. However, potential investors should be mindful of sectoral risks and the evolving market environment. The company's strategic partnerships and diversified product portfolio make it a key player in the healthcare industry.
Fundamental Rating
Merck & Co., Inc. showcases a solid fundamental position with strengths in discounted cash flow and return on equity. However, it faces challenges in its debt-to-equity structure.
| Category | Score | Visualization |
|---|---|---|
| Overall Score | 4 | |
| Discounted Cash Flow | 5 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 3 | |
| Price to Book | 2 |
Historical Rating
Historical data of Merck & Co., Inc. highlights consistency in its discounted cash flow and return metrics while noting any shifts in its overall market positioning.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-07-18 | 4 | 5 | 5 | 5 | 1 | 3 | 2 |
| Previous | 0 | 5 | 5 | 5 | 1 | 3 | 2 |
Analyst Price Targets
Analysts project a solid growth trajectory for Merck & Co., Inc. with a bullish consensus reflected in their median price targets.
| High | Low | Median | Consensus |
|---|---|---|---|
| $98 | $82 | $90 | $90 |
Analyst Sentiment
Analysts maintain a positive outlook on Merck & Co., Inc. with a marked inclination towards 'Buy' recommendations, signaling confidence in its current strategy and market position.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 25 | |
| Hold | 9 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Merck & Co., Inc. exhibits formidable strengths in key financial metrics and maintains a strong market presence through strategic collaborations and an expansive product portfolio. Potential investments are buttressed by a positive analyst consensus, though challenges lie in optimizing its debt-to-equity structure. The company’s robust fundamentals and growth prospects present significant opportunities tempered by sectoral volatility risks.